| Title: | Deep learning to predict left ventricular hypertrophy from the electrocardiogram |
| Journal: | EP Europace |
| Published: | 23 Jan 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41589068/ |
| DOI: | https://doi.org/10.1093/europace/euag015 |
Publication 18495
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
AIMS: Left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular disease. We previously compared supervised machine learning techniques to classify cardiac magnetic resonance (CMR)-derived LVH using electrocardiogram (ECG) and clinical variables in 37 534 UK Biobank participants, obtaining an area under the receiving operating curve (AUROC) of 0.85, but with limited specificity and requiring external validation. In this study, we develop a deep learning (DL) model to improve classification with external evaluation in the Study of Health in Pomerania (SHIP).</p>
METHODS AND RESULTS: We analysed 12-lead ECGs of 48 835 participants from the UK Biobank imaging study. The dataset was split into a training set (70%), validation set (15%), and test set (15%) for performance evaluation. The model architecture was a fully convolutional network, for which the input was the participants' median ECG and clinical variables and the predicted indexed left ventricular mass (iLVM) as the output. A subsequent logistic regression model was used to recalibrate iLVM predictions. In UK Biobank, 717 (1.5%) participants had CMR-derived LVH and the AUROC for the DL model was 0.97. The ECG components most predictive of LVH were the QRS complex and ventricular rate. The DL model outperformed our supervised algorithms, previous DL modelling efforts and clinical ECG benchmarks. There was modest generalizability of the DL model to 1423 participants in SHIP (AUROC 0.78), with differences in clinical profile, ECG acquisition, and CMR labelling as important factors.</p>
CONCLUSION: Our findings support the feasibility of scalable DL-based screening tools for the prediction of LVH from the ECG, whilst highlighting the need for model development using larger datasets with greater diversity to ensure generalizability.</p>
11 Keywords
- Aged
- Deep Learning
- Electrocardiography
- Female
- Humans
- Hypertrophy, Left Ventricular
- Male
- Middle Aged
- Predictive Value of Tests
- Reproducibility of Results
- United Kingdom
13 Authors
- Hafiz Naderi
- Thomas Kaplan
- Stefan van Duijvenboden
- Esmeralda Ruiz Pujadas
- Nay Aung
- C Anwar A Chahal
- Karim Lekadir
- Bishwas Chamling
- Marcus Dörr
- Marcello R P Markus
- Steffen E Petersen
- Julia Ramírez
- Patricia B Munroe
1 Application
| Application ID | Title |
|---|---|
| 2964 | Description of cardiovascular phenotype in the UK Biobank population based on cardiovascular magnetic resonance and carotid ultrasound |
Enabling scientific discoveries that improve human health